Effect of glucantime on field and patient isolates of New World Leishmania: Use of growth parameters of promastigotes to assess antimony susceptibility

Parasitology Research

Volumn 84, Issue 9, 1998, Pages 720-726

  Moreira, Elizabeth Spangler Andrade ^a   Anacleto, Charles ^a   De Petrillo Peixoto, Maria Lourdes ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GEL ELECTROPHORESIS; GENETIC HETEROGENEITY; GROWTH RATE; IN VITRO STUDY; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SOUTHERN BLOTTING; STRAIN DIFFERENCE;

ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; DNA, PROTOZOAN; HUMANS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA GUYANENSIS; MEGLUMINE; OPEN READING FRAMES; ORGANOMETALLIC COMPOUNDS; SPECIES SPECIFICITY;

ANIMALIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA GUYANENSIS; PROTOZOA;

EID: 0031659812     PISSN: 00443255     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004360050476     Document Type: Article

References (28)

1. Berman JD, Wyler DJ (1980) An in vitro model for investigation for chemotherapeutic agents in leishmaniasis. J Infect Dis 142: 83-86
2. Berman JD, Waddell D, Hanson B (1985) Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate. Antimicrob Agents Chemother 27: 916-920
3. Berman JD, Edwards N, King M, Grogl M (1989) Biochemistry of pentostam resistant Leishmania. Am J Trop Med Hyg 40: 159-164
4. Beverley SM (1991) Gene amplification in Leishmania. Annu Rev Microbiol 45: 417-444
5. Borst P, Oullette M (1995) New mechanisms of drug resistance in parasitic protozoa. Annu Rev Microbiol 49: 427-460
6. Callahan HL, Beverley SM (1991) Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem 266: 18424-18430
7. Callahan HL, Roberts WL, Rainey PM, Beverley SM (1994) The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux. Mol Biochem Parasitol 68: 145-149
8. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995
9. Coderre JA, Beverley SM, Schimke RT, Santi DV (1983) Over-production of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrex-ate-resistant Leishmania tropica. Proc Natl Acad Sci USA 80: 2132-2136
10. Croft SL (1986) In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis. Parasitol Today 2: 64-69
11. Croft SL, Urbina JA, Brun R (1997) Chemotherapy of human leishmaniasis and trypanosomiasis. In: Mottram JC, Coombs GH, Holmes PH (eds) Trypanosomiasis and leishmaniasis CAB International, New York, pp 245-257
12. Dey S, Papadopoulou B, Haimeur A, Roy G, Grodin K, Dou D, Rosen BP, Ouellette M (1994) High level of arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol Biochem Parasitol 67: 49-57
13. Ellenberger TE, Beverley SM (1989) Multiple drug resistance and conservative amplification of the na region in Leishmania major. J Biol Chem 264: 15094-15103
14. Ephros M, Waldman E, Zilberstein D (1997) Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob Agents Chemother 41: 1064-1068
15. Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41: 827-830
16. Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137: 266-267
17. Ferreira-Pinto KC, Miranda-Vilela AL, Anacleto C, Fernandes APSM, Abdo MCB, Petrillo-Peixoto ML, Moreira ESA (1996) Leishmania (Viannia) guyanensis: isolation and characterization of glucantime-resistant cell lines. Can J Microbiol 42: 944-946
18. Figueiredo Y, Costa CA, Mayrink W, Araüjo FG, Dias M, Mélo MN, Magalhães P, Willians P, Batista SM, Coelho MV (1976) Nutrição e metabolismo de formas de cultura de Leishmania. Rev Inst Med Trop Sao Paulo 18: 306-314
19. Filard LS, Brener Z (1987) Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Trans R Soc Trop Med Hyg 81: 755-759
20. Grogl M, Oduola AMJ, Corder LDC, Kyle DE (1989) Leishmania spp. development of pentostam-resistant clones in vitro by discontinuous drug exposure. Exp Parasitol 69: 78-90
21. Grogl M, Thomason TN, Franke ED (1992) Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 47: 117-126
22. Grondin K, Papadopoulou B, Ouellette M (1993) Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res 21: 1895-1901
23. Ibrahim ME, Hag-Ali M, El-Hassan AM, Theander TG, Kharazml A (1994) Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing. Parasitol Res 80: 569-574
24. Jackson JE, Tally JD, Ellis WY, Mebrahtu YB, Lawyer PG, Were JB, Reed SG, Panisko DM, Limmer BL (1990) Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy. Am J Trop Med Hyg 43: 464-480
25. Lainson R (1983) The American leishmaniasis: some observations on their ecology and epidemiology. Trans R Soc Trop Med Hyg 77: 564-596
26. Legaré D, Hettema E, Ouellette M (1994) The P-glycoprotein-related gene family in Leishmania. Mol Biochem Parasitol 68: 81-91
27. Moreira ESA, Petrillo-Peixoto ML (1991) In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes. Braz J Med Biol Res 24: 459-469
28. Moreira ESA, Guerra JB, Petrillo-Peixoto ML (1992) Glucantime resistant Leishmania promastigotes are sensitive to pentostam. Rev Soc Bras Med Trop 25: 247-250